Skip to content
Screener

Fulgent Genetics, Inc. FLGT Laboratory Services — Operating Income

Other segment segments

Therapeutic Development
-$4.46M-4.8%

Similar metrics at other companies

Labcorp Holdings logo
LHBiopharma Laboratory Services — Operating Income
$120.7M+12.9%
Corvex logo
MOVEConnected Devices And Services — Operating Income
-$3.21M+38.7%
CoreCivic logo
CXWServices — Operating Income
$9.04M+1,211%
Consolidated Water Company logo
CWCOServices — Operating Income
$424.44K-70.3%
Transcat logo
TRNSService — Operating Income
$3.51M-41.3%
Deere & Company logo
DEFinancial Services — Operating Income
$251M+21.3%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Three Months Ended March 31, 2026Laboratory ServicesTherapeutic DevelopmentTotal
Revenue$71,051$87$71,138
Less:
Adjusted cost of revenue48,179848,187
Adjusted research and development6,4614,17810,639
Adjusted selling and marketing11,57611,576
Adjusted general and administrative20,05235720,409
Total adjusted operating loss$(15,217)$(4,456)$(19,673)

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s laboratory services — operating income?
Fulgent Genetics, Inc. (FLGT) reported laboratory services — operating income of -$15.22M in Q1 2026.
How has Fulgent Genetics, Inc.'s laboratory services — operating income changed year-over-year?
Fulgent Genetics, Inc.'s laboratory services — operating income decreased by 406.6% year-over-year, from -$3M to -$15.22M.
What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — operating income?
Over 2 years (2021 to 2025), Fulgent Genetics, Inc.'s laboratory services — operating income has grown at a -89.5% compound annual growth rate (CAGR), from $675.95M to -$7.51M.
What does laboratory services — operating income mean?
This is the profit or loss generated by the laboratory services segment after deducting operating expenses from total segment revenue. It provides a clear view of the core operational profitability of the laboratory business, excluding non-operating items like interest and taxes.

Ask your AI about Fulgent Genetics, Inc.'s laboratory services — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude